0
Industry
Geography
Report Type
Themes
Price
Publication date
Published Date
  • Product Insights

    New
    $3,500 | June 2024
    Product Insights
    New

    Claudin 18 – Drugs In Development, 2024

    The Claudin 18 pipeline drugs market research report outlays comprehensive information on the Claudin 18 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, and Undisclosed which include indications of Gastric Cancer, Solid Tumor, and Unspecified. It also reviews key players involved in Claudin 18 targeted therapeutics development with respective active and dormant or discontinued projects. Note:...

  • Product Insights

    New
    $3,500 | June 2024
    Product Insights
    New

    NS5B – Drugs In Development, 2024

    The NS5B pipeline drugs market research report outlays comprehensive information on the NS5B targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Infectious Disease which include indications of Hepatitis C, and Coronavirus Disease 2019 (COVID-19). It also reviews key players involved in NS5B targeted therapeutics development with respective active and dormant or discontinued projects. Note: * This is...

  • Product Insights

    New
    $3,500 | June 2024
    Product Insights
    New

    Phenylalanine 4 Hydroxylase – Drugs In Development, 2024

    The Phenylalanine 4 Hydroxylase pipeline drugs market research report outlays comprehensive information on the Phenylalanine 4 Hydroxylase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Metabolic Disorders which include indications of Phenylketonuria (PKU). It also reviews key players involved in Phenylalanine 4 Hydroxylase targeted therapeutics development with respective active and dormant or discontinued projects. Note: * This...

  • Product Insights

    New
    $3,500 | June 2024
    Product Insights
    New

    Frataxin Mitochondrial – Drugs In Development, 2024

    The Frataxin Mitochondrial pipeline drugs market research report outlays comprehensive information on the Frataxin Mitochondrial targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, and Cardiovascular which include indications of Friedreich Ataxia, and Cardiomyopathy. It also reviews key players involved in Frataxin Mitochondrial targeted therapeutics development with respective active and dormant or discontinued projects. Note:...

  • Product Insights

    New
    $3,500 | June 2024
    Product Insights
    New

    Glypican 3 – Drugs In Development, 2024

    The Glypican 3 pipeline drugs market research report outlays comprehensive information on the Glypican 3 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology which include indications of Hepatocellular Carcinoma, and Solid Tumor. It also reviews key players involved in Glypican 3 targeted therapeutics development with respective active and dormant or discontinued projects. Note: * This is...

  • Product Insights

    New
    $3,500 | June 2024
    Product Insights
    New

    Cholinesterase – Drugs In Development, 2024

    The Cholinesterase pipeline drugs market research report outlays comprehensive information on the Cholinesterase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, and Cardiovascular which include indications of Alzheimer's Disease, Dementia, and Ischemic Stroke. It also reviews key players involved in Cholinesterase targeted therapeutics development with respective active and dormant or discontinued projects. Note: *...

  • Product Insights

    New
    $3,500 | June 2024
    Product Insights
    New

    Exodeoxyribonuclease III – Drugs In Development, 2024

    The Exodeoxyribonuclease III pipeline drugs market research report outlays comprehensive information on the Exodeoxyribonuclease III targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology which include indications of Solid Tumor, and Unspecified Cancer. It also reviews key players involved in Exodeoxyribonuclease III targeted therapeutics development with respective active and dormant or discontinued projects. Note: * This is...

  • Product Insights

    New
    $3,500 | June 2024
    Product Insights
    New

    HIV Integrase – Drugs In Development, 2024

    The HIV Integrase pipeline drugs market research report outlays comprehensive information on the HIV Integrase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Infectious Disease which include indications of Human Immunodeficiency Virus (HIV) Infections (AIDS), and Tuberculosis. It also reviews key players involved in HIV Integrase targeted therapeutics development with respective active and dormant or discontinued projects....

  • Product Insights

    New
    $3,500 | June 2024
    Product Insights
    New

    Angiopoietin 2 – Drugs In Development, 2024

    The Angiopoietin 2 pipeline drugs market research report outlays comprehensive information on the Angiopoietin 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Ophthalmology, Oncology, and Undisclosed which include indications of Wet (Neovascular / Exudative) Macular Degeneration, Diabetic Macular Edema, Oncology, Metastatic Melanoma, and Unspecified. It also reviews key players involved in Angiopoietin 2 targeted therapeutics development...

  • Product Insights

    New
    $3,500 | June 2024
    Product Insights
    New

    Ribonucleoside Diphosphate Reductase Large Subunit – Drugs In Development, 2024

    The Ribonucleoside Diphosphate Reductase Large Subunit pipeline drugs market research report outlays comprehensive information on the Ribonucleoside Diphosphate Reductase Large Subunit targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology which include indications of Pancreatic Cancer, and Solid Tumor. It also reviews key players involved in Ribonucleoside Diphosphate Reductase Large Subunit targeted therapeutics development with respective active...

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.